BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 11, 2010
View Archived Issues
Finding 'Medically Actionable Alleles' in Genomic Haystack
Read More
Biotech's Future: BioWorld Gives You 2020 Vision in 2010!
Read More
Other News To Note
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Financings Roundup
Read More
Facet Biotech Wooed by $722M Acquisition Offer from Abbott
Three months after Biogen Idec Inc. failed to acquire Facet Biotech Corp. for $17.50 per share, Abbott is getting the job done with a $27-per-share offer. (BioWorld Today)
Read More
Immunotherapy Still an 'Option,' Transgene-Novartis Deal Proves
Read More